Proteinuria During Long-term Captopril Therapy
Overview
Affiliations
Proteinuria developed in six of 81 hypertensive patients given captopril for at least four months (protein excretion, greater than 200 mg/24 hr). Two had previously elevated protein excretion. In all patients the increased protein excretion occurred by the fourth month of treatment. It subsided in four after two to nine months, despite continued therapy. In two of the four, proteinuria cleared completely within seven months after onset, while in the other two it subsided to the range of 600 mg/24 hr. However, in the remaining two patients proteinuria persisted during captopril therapy and was associated with hypoalbuminemia and hypercholesterolemia. Renal biopsy specimens showed mild membranous nephropathy in two patients, one of whom had a remittance of proteinuria during continued captopril treatment.
Velkoska E, Dean R, Burchill L, Levidiotis V, Burrell L Clin Sci (Lond). 2009; 118(4):269-79.
PMID: 19698082 PMC: 2782317. DOI: 10.1042/CS20090318.
ACE inhibitors and proteinuria.
Gansevoort R, de Zeeuw D, de Jong P Pharm World Sci. 1996; 18(6):204-10.
PMID: 9010883 DOI: 10.1007/BF00735961.
How adverse drug reactions can play a role in innovative drug research.
Rikken F, Vos R Pharm World Sci. 1995; 17(6):195-200.
PMID: 8597776 DOI: 10.1007/BF01870611.
Effect of captopril on renal function in patients with congestive heart failure.
Pierpont G, Francis G, Cohn J Br Heart J. 1981; 46(5):522-7.
PMID: 7032555 PMC: 482690. DOI: 10.1136/hrt.46.5.522.
Adverse effects of antihypertensive drugs.
Husserl F, Messerli F Drugs. 1981; 22(3):188-210.
PMID: 7021123 DOI: 10.2165/00003495-198122030-00002.